Correlation between fatigue and quality of life among patients with neuromyelitis optica in West China. [PDF]
Miao X, Liu Q.
europepmc +1 more source
Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder. [PDF]
Koc ER +40 more
europepmc +1 more source
Lipoprotein dynamics in neuromyelitis optica spectrum disorder. [PDF]
Liu TW +4 more
europepmc +1 more source
Perioperative anesthetic challenges in neuromyelitis optica: balancing safety and relapse risk with neurotechnology. [PDF]
Anwar S +7 more
europepmc +1 more source
Peripheral blood immune inflammatory markers in neuromyelitis optica spectrum disorders. [PDF]
Wu B, Cao F, Mao M, Gong X, Xu B.
europepmc +1 more source
Relapse-related outcomes in the Danish population-based AQP4- antibody seropositive neuromyelitis optica spectrum disorder cohort. [PDF]
Mamoei S +10 more
europepmc +1 more source
A blood-based co-expression signature of LncRNAs and transcription factors in neuromyelitis optica with diagnostic and mechanistic implications. [PDF]
Ghafouri-Fard S +3 more
europepmc +1 more source
Switching from Rituximab to Eculizumab in US Patients with Neuromyelitis Optica Spectrum Disorder: Impact on Hospitalizations. [PDF]
Lee J +4 more
europepmc +1 more source
Systemic Lupus Erythematosus in a patient with Aquaporin 4-Positive Neuromyelitis Optica Spectrum Disorder. [PDF]
Saha S.
europepmc +1 more source

